System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Epublish 1 citation

PubMed: 39640263 DOI: 10.3389/fimmu.2024.1494432

Long-term COVID-19 vaccine- and Omicron infection-induced humoral and cell-mediated immunity.

Front Immunol 15:1494432

Authors: Milja Belik, Arttu Reinholm, Pekka Kolehmainen, Jemna Heroum, Sari Maljanen, Eda Altan, Pamela Österlund, Larissa Laine, Olli Ritvos, Arja Pasternack, Rauno A Naves, Alina Iakubovskaia, Alex-Mikael Barkoff, Qiushui He, Johanna Lempainen, Paula A Tähtinen, Lauri Ivaska, Pinja Jalkanen, Ilkka Julkunen, Laura Kakkola

Affiliations

  • Institute of Biomedicine, University of Turku, Turku, Finland.
  • Microbiology Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Department of Physiology, Medicum, University of Helsinki, Helsinki, Finland.
  • InFlames Research Flagship Center, University of Turku, Turku, Finland.
  • Department of Paediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland.
  • Clinical Microbiology, Turku University Hospital, Turku, Finland.

Abstract

Introduction

Mutations occurring in the spike (S) protein of SARS-CoV-2 enables the virus to evade COVID-19 vaccine- and infection-induced immunity.

Methods

Here we provide a comprehensive analysis of humoral and cell-mediated immunity in 111 healthcare workers who received three or four vaccine doses and were followed up to 12 and 6 months, respectively, after the last vaccine dose. Omicron breakthrough infection occurred in 71% of the vaccinees, enabling evaluation of vaccine- and vaccine/infection-induced hybrid immunity.

Results

Neutralizing antibodies were the highest against the ancestral D614G and were sequentially reduced against the Omicron variants BA.2, BA.5 and XBB.1.5. S1-specific IgG and neutralizing antibody levels were significantly higher in infected than in uninfected vaccinees, and the fourth vaccine dose in combination with a breakthrough infection resulted in high neutralizing antibody levels against all variants. T cell-mediated immunity, instead, was well retained already after two vaccine doses, and was not significantly strengthened by additional booster vaccine doses or Omicron breakthrough infections.

Discussion

While humoral immunity is sensitive to mutations in the S protein and thus declined rapidly, the cell-mediated immunity is durable to antigenic variation, which may explain the good efficacy of COVID-19 vaccines against a severe disease.

MeSH

Cells, Vaccines, Covid-19 Vaccines, Antibodies, Neutralizing, Immunity, Cellular, Covid-19, Immunity, Infections, Breakthrough Infections

Cited by